There are several reports of disordered oesophageal function in patients with Parkinson's disease. Segmental spasm has been noted radiologically (Penner and Druckermann, 1942; Eadie and Tyrer, 1965a) as has oesophageal dilatation (Gibberd et al., 1974) and gastro-oesophageal reflux (Eadie and Tyrer, 1965a) . Only a few patients have been studied using manometric techniques, an increased incidence of non-peristaltic swallows being observed (Fischer et al., 1965) . As dysphagia is common in Parkinson's disease (Eadie and Tyrer, 1965b) more detailed investigations into oesophageal motility were undertaken. Vagal function was also assessed.
Methods
Twenty unselected patients with idiopathic Parkinson's disease and 20 control subjects, matched for age and sex, gave informed consent before entering the study. Mean (Jean, 1972; Roman and Tieffenbach, 1972; Sumi, 1972) . Local distension initiating peristalsis (Christensen and Lund, 1969) was not studied. The significant disruption of peristalsis in Parkinsonism patients after atropine was unexpected as other Evidence for a change in neurotransmitter aflecting oesophageal motility features such as tremor improved. In contrast, bethanechol worsened tremor and rigidity without affecting peristalsis significantly compared with control subjects. Improvement on anticholinergics and deterioration after cholinomimetics is well known (Duvoisin, 1967) and implies that either increased acetylcholine production or increased sensitivity is responsible for many symptoms of Parkinsonism.
The dorsal vagal nucleus, however, appears to maintain normal function since no abnormalities are detected during the first 25 minutes. The dramatic effect of atropine provides indirect evidence of a change of neurotransmitter. Thus cholinergic neurones may be replacing the functions of degenerating dopaminergic neurones quite effectively (Spehlman and Stahl, 1976) . Overcompensation may be deleterious and produce dysphagia, as this symptom was associated with the highest incidence of disruption in peristalsis after atropine. Evidence already exists that the dorsal vagal nucleus is morphologically abnormal in Parkinson's disease (Eadie, 1963) , and Fischer et al. (1965) noted increased motor dysfunction in a small number of patients on anti-cholinergics in the only other manometric study.
Autonomic dysfunction from a central abnormality has been observed in the presence of both normal and abnormal Valsalva responses (Appenzeller and Goss, 1971; Gross et al., 1972) . Allowing for age, it seems unlikely that a vagal neuropathy exists in Parkinson's disease, and the present study, using two simple parameters, shows no difference between Parkinsonism patients and control subjects.
Circular oesophageal smooth muscle is controlled principally by cholinergic mechanisms although adrenergic (Christensen, 1975) and dopaminergic (Rattan and Goyal, 1976) receptors exist. In man, dopamine increases the amplitude of contractions in the body of the oesophagus while reducing LOSP (Mukhopadhyay and Weisbrodt, 1977) . Patients severely affected with Parkinsonism tended to have a slightly higher LOSP and reduced response to bethanechol consistent with peripheral dopamine depletion, as the LOSP is not under vagal control (Rattan and Goyal, 1974) . However, the differences were not significant and no conclusions can be drawn from this limited evidence.
Finally, how does the present study relate to previous cineradiological findings? Comparison is difficult although manometry is able to examine peristalsis and measure pressures more effectively. Using this technique, no oesophageal spasm was detected in nearly nine hours of resting motor activity and over 400 swallows. Eadie and Tyrer (1965a) 
